The Latest Breaking News from FDA

Though doctors and advocates have helped speed up access to the antiviral pills – of which the U.S. has enough to treat 1.7 million people – health providers are few and forms are still required.

The U.S. Food and Drug Administration (FDA) has approved Arcutis Biotherapeutics’ (NASDAQ:ARQT) New Drug Application (NDA) for ZORYVE (roflumilast) cream 0.3% for the treatment of plaque psoriasis in patients 12 years of age or older. The company expects commercial launch of the product in Mid-August. Arcutis shares traded in a range of…

Here's a roundup of top developments in the biotech space over the last 24 hours:

CHARLOTTE, N.C. — As COVID-19 cases soar around the country, fake treatments continue to linger on the open market, posing a safety risk to those seeking medical care.

The Court should assimilate the “major questions” doctrine of West Virginia v. EPA and its precedents—including Chevron and what came even before that—to an approach that asks whether Congress has made an actual delegation. Only this will serve the relevant separation-of-powers principle.

Mark Grenon, who runs a ‘non-religious church’, charged for selling toxic industrial bleach as Covid cure

The Biden administration is scrapping plans to offer COVID boosters for people under 50 this summer. Instead they will push for an earlier release of the next generation boosters in the fall.

Here's a roundup of top developments in the biotech space over the last 24 hours:

Altria reports its nearly $13 billion investment in troubled vaping company Juul is worth 95% less than it originally paid

Democrats fear that red, anti-abortion states could restrict or even ban birth control.

You may have seen a “Pink Sauce” headline in your social feeds sometime in the past week. Maybe you skipped over it, but now it’s hard to escape. The Pink Sauce situation is real, and chef Carly Pii is taking it very, very personally.